Use is restricted to qualified personnel in scientific research environments

Water, Methylpropanediol, Glycerin, Beta-Glucan, Dimethicone, Titanium Dioxide, Niacinamide, Cyclopentasiloxane, Betaine, Polyglycerin-3, Eclipta Prostrata Leaf Extract, Laminaria Japonica Extract, 1,2-Hexanediol, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Sodium Polyacrylate, Ethylhexyl Stearate, Isohexadecane, Panthenol, Dimethiconol, Hydroxyacetophenone, Butylene Glycol, Polysorbate 80, Centella Asiatica Extract, Ficus Carica (Fig) Fruit Extract, Fragrance, Glutathione, Glycyrrhiza Glabra (Licorice) Root Extract, Lactobacillus/Rice Ferment, Sorbitan Oleate, Triethoxycaprylylsilane, Trideceth-6, Hydrogenated Lecithin, Fructooligosaccharides, Hydrogenated Polyisobutene, Squalane, Disodium Edta, Argania Spinosa Kernel Oil, Isononyl Isononanoate, Polyglyceryl-10 Stearate, Amaranthus Caudatus Seed Extract, Butyrospermum Parkii (Shea) Butter, Cetearyl Alcohol, Panax Ginseng Root Extract, Polyglyceryl-2 Dipolyhydroxystearate, Stearic Acid, Ulmus Davidiana Root Extract, Hydrolyzed Hyaluronic Acid, Inulin Lauryl Carbamate, Carbomer, Pearl Powder, Ceramide Np, Polysorbate 20, Disodium Stearoyl Glutamate, Palmitoyl Pentapeptide-4

TSA Guidelines for Semaglutide in Security Checks The Transportation Security Administration (TSA) recognizes that passengers with medical needs must carry essential medications, and semaglutide is no exception
The phase 3 trial is in 8,000+ patients with established cardiovascular disease and elevated Lp(a) with a hard primary endpoint composite of cardiovascular death, myocardial infarction, stroke, or urgent coronary revascularization requiring hospitalization
However, animal studies indicate an increased risk of miscarriage and birth defects